Jang SJ - Search Results

1

The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy.

Ahn SM, Ansari AA, Kim J, Kim D, Chun SM, Kim J, Kim TW, Park I, Yu CS, Jang SJ. Ahn SM, et al. Among authors: jang sj. Oncotarget. 2016 Oct 18;7(42):68638-68649. doi: 10.18632/oncotarget.11862. Oncotarget. 2016. PMID: 27612425 Free PMC article.

2

Optimal time interval between capecitabine intake and radiotherapy in preoperative chemoradiation for locally advanced rectal cancer.

Yu CS, Kim TW, Kim JH, Choi WS, Kim HC, Chang HM, Ryu MH, Jang SJ, Ahn SD, Lee SW, Shin SS, Choi EK, Kim JC. Yu CS, et al. Among authors: jang sj. Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1020-6. doi: 10.1016/j.ijrobp.2006.10.013. Epub 2006 Dec 29. Int J Radiat Oncol Biol Phys. 2007. PMID: 17197127

3

Extrapulmonary small cell carcinoma: single center experience with 61 patients.

Lee SS, Lee JL, Ryu MH, Chang HM, Kim TW, Kim WK, Lee JS, Jang SJ, Khang SK, Kang YK. Lee SS, et al. Among authors: jang sj. Acta Oncol. 2007;46(6):846-51. doi: 10.1080/02841860601071893. Acta Oncol. 2007. PMID: 17653910

4

Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.

Park IJ, Kim HC, Yu CS, Kim TW, Jang SJ, Kim JC. Park IJ, et al. Among authors: jang sj. Ann Surg Oncol. 2008 Feb;15(2):519-25. doi: 10.1245/s10434-007-9643-x. Epub 2007 Oct 25. Ann Surg Oncol. 2008. PMID: 17960464

5

PDGFRalpha gene mutation and protein expression in gastrointestinal stromal tumors.

Chang HM, Ryu MH, Lee H, Jang SJ, Lee JL, Kim TW, Yook JH, Oh ST, Kim BS, Lee JS, Kang YK. Chang HM, et al. Among authors: jang sj. Oncology. 2008;74(1-2):88-95. doi: 10.1159/000139136. Epub 2008 Jun 12. Oncology. 2008. PMID: 18547963

6

EC-18, a synthetic monoacetyldiacylglyceride, inhibits hematogenous metastasis of KIGB-5 biliary cancer cell in hamster model.

Kim MH, Chang HM, Kim TW, Lee SK, Park JS, Kim YH, Lee TY, Jang SJ, Suh CW, Lee TS, Kim SH, Lee SG. Kim MH, et al. Among authors: jang sj. J Korean Med Sci. 2009 Jun;24(3):474-80. doi: 10.3346/jkms.2009.24.3.474. Epub 2009 Jun 12. J Korean Med Sci. 2009. PMID: 19543512 Free PMC article.

7

The role of KRAS mutations in predicting the efficacy of cetuximab-plus-irinotecan therapy in irinotecan-refractory Korean metastatic colorectal cancer patients.

Sohn BS, Kim TW, Lee JL, Ryu MH, Chang HM, Kang YK, Park HS, Na YS, Jang SJ, Kim JC, Lee JS. Sohn BS, et al. Among authors: jang sj. Oncology. 2009;77(3-4):224-30. doi: 10.1159/000236046. Epub 2009 Sep 7. Oncology. 2009. PMID: 19738388

8

Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors of the stomach: report of three cases.

Oh JS, Lee JL, Kim MJ, Ryu MH, Chang HM, Kim TW, Jang SJ, Yook JH, Oh ST, Kim BS, Kang YK. Oh JS, et al. Among authors: jang sj. Cancer Res Treat. 2006;38(3):178-83. doi: 10.4143/crt.2006.38.3.178. Epub 2006 Jun 30. Cancer Res Treat. 2006. PMID: 19771279 Free PMC article.

9

Prognostic significance of lymphovascular invasion in sporadic colorectal cancer.

Lim SB, Yu CS, Jang SJ, Kim TW, Kim JH, Kim JC. Lim SB, et al. Among authors: jang sj. Dis Colon Rectum. 2010 Apr;53(4):377-84. doi: 10.1007/DCR.0b013e3181cf8ae5. Dis Colon Rectum. 2010. PMID: 20305435

10

Upregulation of SPRR3 promotes colorectal tumorigenesis.

Cho DH, Jo YK, Roh SA, Na YS, Kim TW, Jang SJ, Kim YS, Kim JC. Cho DH, et al. Among authors: jang sj. Mol Med. 2010 Jul-Aug;16(7-8):271-7. doi: 10.2119/molmed.2009.00187. Epub 2010 Mar 17. Mol Med. 2010. PMID: 20379613 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

859 results

Search Page

Filters